178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Li Liu, Simon Turcotte, Shari Pilon-Thomas, Doris Wiener, Brian Czerniecki, Matthew Beatty, Larissa Pikor, Urminder Singh, Christian E Laing, Jacob Gibson, Anna Kluew, Mahdi Golkaram, Sven Bilke, Nathalie Brassard, Stewart E Abbot, Timothy J Langer, Grace DeSantis, Michael J Ciancanelli, Jeff H Tsai
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	BMJ Publishing Group 2023-11-01
Σειρά:	Journal for ImmunoTherapy of Cancer

Παρόμοια τεκμήρια

900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
ανά: Quanyuan He, κ.ά.
Έκδοση: (2023-11-01)

346 Expansion and identification of neoantigen reactive tumor infiltrating lymphocytes (TIL) from metastatic colorectal (CRC) and GI cancers
ανά: Amy Hall, κ.ά.
Έκδοση: (2023-11-01)

Tumor neoantigens and tumor immunotherapies
ανά: Wang Jiani, κ.ά.
Έκδοση: (2024-04-01)

Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing
ανά: Meng Jia, κ.ά.
Έκδοση: (2023-10-01)

The interplay between cancer type, panel size and tumor mutational burden threshold in patient selection for cancer immunotherapy.
ανά: Mahdi Golkaram, κ.ά.
Έκδοση: (2020-11-01)

The Development of Tumor Neoantigen Vaccine Immunotherapy
ανά: Wang Wanqiu
Έκδοση: (2019-01-01)

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
ανά: Markus W. Löffler, κ.ά.
Έκδοση: (2019-04-01)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
ανά: Kim Bich Nguyen, κ.ά.
Έκδοση: (2023-08-01)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
ανά: Zhe Jing, κ.ά.
Έκδοση: (2022-08-01)

Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
ανά: Stefani Spranger, κ.ά.
Έκδοση: (2024-11-01)

Computational Prediction and Validation of Tumor-Associated Neoantigens
ανά: Vladimir Roudko, κ.ά.
Έκδοση: (2020-01-01)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
ανά: Zheying Zhang, κ.ά.
Έκδοση: (2021-04-01)

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
ανά: Brandon Mistretta, κ.ά.
Έκδοση: (2023-09-01)

Utilization of primary tumor samples for cancer neoantigen discovery
ανά: Yong Li, κ.ά.
Έκδοση: (2025-01-01)

Tumor neoantigens: from basic research to clinical applications
ανά: Tao Jiang, κ.ά.
Έκδοση: (2019-09-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
ανά: Yanwei Shen, κ.ά.
Έκδοση: (2022-08-01)

Inducible de novo expression of neoantigens in tumor cells and mice
ανά: Damo, Martina, κ.ά.
Έκδοση: (2021)

Inducible de novo expression of neoantigens in tumor cells and mice
ανά: Damo, Martina, κ.ά.
Έκδοση: (2022)

Automated Flow Synthesis of Tumor Neoantigen Peptides for Personalized Immunotherapy
ανά: Truex, Nicholas, κ.ά.
Έκδοση: (2020)

Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
ανά: Berta Segura-Collar, κ.ά.
Έκδοση: (2023-05-01)

The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
ανά: Zhiting Wei, κ.ά.
Έκδοση: (2019-11-01)

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
ανά: Vrunda Trivedi, κ.ά.
Έκδοση: (2024-01-01)

The clonal hydra: neoantigen-specific T-cell response in germ cell tumors
ανά: Shefali Mehra, κ.ά.
Έκδοση: (2024-01-01)

Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
ανά: Xiaoyu Huang, κ.ά.
Έκδοση: (2024-03-01)

Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
ανά: Guadalupe Nibeyro, κ.ά.
Έκδοση: (2023-07-01)

Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
ανά: Berta Segura-Collar, κ.ά.
Έκδοση: (2023-07-01)

The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
ανά: Ahmet Murat Aydin, κ.ά.
Έκδοση: (2021-02-01)

Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
ανά: Shari Pilon-Thomas, κ.ά.
Έκδοση: (2023-10-01)

Analysis of Somatic Mutations in the TCGA-LIHC Whole Exome Sequence to Identify the Neoantigen for Immunotherapy in Hepatocellular Carcinoma
ανά: Swetha Pulakuntla, κ.ά.
Έκδοση: (2023-12-01)

Unraveling the power of NAP-CNB’s machine learning-enhanced tumor neoantigen prediction
ανά: Almudena Mendez-Perez, κ.ά.
Έκδοση: (2025-03-01)

TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis
ανά: Jingcheng Wu, κ.ά.
Έκδοση: (2018-08-01)

Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification
ανά: Celina Tretter, κ.ά.
Έκδοση: (2023-08-01)

Establishment of a novel tumor neoantigen prediction tool for personalized vaccine design
ανά: Kai Xin, κ.ά.
Έκδοση: (2024-12-01)

Ionizable polymeric nanocarriers for the codelivery of bi-adjuvant and neoantigens in combination tumor immunotherapy
ανά: Ting Su, κ.ά.
Έκδοση: (2023-08-01)

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
ανά: Jiangping Li, κ.ά.
Έκδοση: (2023-08-01)

Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
ανά: Songming Peng, κ.ά.
Έκδοση: (2019-09-01)

TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
ανά: Yunxia Tang, κ.ά.
Έκδοση: (2020-11-01)

Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
ανά: Manisit Das, κ.ά.
Έκδοση: (2020-12-01)

The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex
ανά: Sang Hoon Kim, κ.ά.
Έκδοση: (2024-06-01)

1461 Induction of clonal expansion of tumor-reactive T cells and effective tumor suppression by neoantigens predicted from the ‘VACINUS‘ platform
ανά: Sang Hoon Kim, κ.ά.
Έκδοση: (2023-11-01)